Home
GNS Healthcare

GNS Healthcare Market Share Analysis for November 2025

Aitia harnesses Causal AI, Multi-Omics data and Gemini Digital Twins to discover the next generation of breakthrough drugs.

Health > Health - Other

Domaingnshealthcare.com

Year Founded2000

Employees51 - 200

Annual Revenue$10M - $15M

GNS Healthcare

GNS Healthcare (including company regionals)

gnshealthcare.com

See more website traffic and engagement information

GNS Healthcare Revenue up to November 2025 is 10M - 15M

revenue generated by GNS Healthcare top domains

GNS Healthcare top domains revenue over 3 years

Revenue for GNS Healthcare top domains

gnshealthcare.com10M - 15M

See more with Sales Intelligence

Total visits to GNS Healthcare's top domains

Understand GNS Healthcare market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in GNS Healthcare's top domains

Analyze GNS Healthcare engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on GNS Healthcare's top domains

See how GNS Healthcare keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

GNS Healthcare top competitors by domain

Top similar sites in November 2025, ranked by their affinity

roche-australia.comCompany NameRocheEmployees> 10001HQSwitzerlandAnnual revenue> $1BTotal visits4.1KHealth > Biotechnology and Pharmaceuticals

Top technologies used by GNS Healthcare

These are the website technologies, by industry, used by GNS Healthcare top domains

Advertising (5)

DoubleClick

Widget (5)

Twemoji

Booking (2)

Eventbrite

Marketing (2)

Google Marketing Platform

More Technologies

12

See all

News & Signals from GNS Healthcare

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsGNS Healthcare, Inc. partnered with Arvinas, Inc. on May 9th '22.GNS Healthcare, the leader in the use of "Virtual Patients", Causal AI and simulation technology for biopharmaceutical companies, today announced a collaboration with Arvinas, Inc. (Nasdaq: ARVN ), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, to generate insights to help accelerate drug development for neurodegenerative diseases.

NewsGNS Healthcare, Inc. hired Joseph F. Donahue as Chief Business Officer on Apr 13th '22.GNS Healthcare, the leader in the use of "Virtual Patients" and Causal AI and simulation technology for biopharmaceutical companies, today announced the hiring of Joseph F. Donahue as Chief Business Officer.

NewsGNS Healthcare, Inc. launches Gemini — The in silico Patient.GNS Healthcare and Scipher Medicine have partnered to develop and launch Gemini — The in silico Patient, for rheumatoid arthritis.